• 1
    Harris, E. D., Rheumatoid arthritis. Pathophysiology and implications for therapy. N. Engl. J. Med 1990. 322: 12771289.
  • 2
    Arend, W. P. and Dayer, J. M., Inhibition of the production and effects of interleukin-1 and tumor necrosis factor a in rheumatoid arthritis. Arthritis Rheum. 1995. 38: 151160.
  • 3
    van Roon, J. A., Bijlsma, J. W. and Lafeber, F. P., Suppression of inflammation and joint destruction in rheumatoid arthritis may require a concerted action of Th2 cytokines. Curr. Opin. Investig. Drugs 2002. 3: 10111016.
  • 4
    Miossec, P. and van den Berg, W., Th1/Th2 cytokine balance in arthritis. Arthritis Rheum. 1997. 40: 21052115.
  • 5
    Lubberts, E., Joosten, L. A., van Den Bersselaar, L., Helsen, M. M., Bakker, A. C., van Meurs, J. B., Graham, F. L. et al., Adenoviral vector-mediated overexpression of IL-4 in the knee joint of mice with collagen-induced arthritis prevents cartilage destruction. J. Immunol. 1999. 163: 45464556.
  • 6
    Ho, S. H., Hahn, W., Lee, H. J., Kim, D. S., Jeong, J. G., Kim, S., Yu, S. S. et al., Protection against collagen-induced arthritis by electrotransfer of an expression plasmid for the interleukin-4. Biochem. Biophys. Res. Commun. 2004. 321: 759766.
  • 7
    Woods, J. M., Amin, M. A., Katschke, K. J., Jr., Volin, M. V., Ruth, J. H., Connors, M. A., Woodruff, D. C. et al., Interleukin-13 gene therapy reduces inflammation, vascularization, and bony destruction in rat adjuvant-induced arthritis. Hum. Gene Ther. 2002. 13: 381393.
  • 8
    Bessis, N., Boissier, M. C., Ferrara, P., Blankenstein, T., Fradelizi, D. and Fournier, C., Attenuation of collagen-induced arthritis in mice by treatment with vector cells engineered to secrete interleukin-13. Eur. J. Immunol. 1996. 26: 23992403.
  • 9
    Boyle, D. L., Nguyen, K. H., Zhuang, S., Shi, Y., McCormack, J. E., Chada, S., Firestein, G. S., Intra-articular IL-4 gene therapy in arthritis: anti-inflammatory effect and enhanced th2activity. Gene Ther. 1999. 6: 19111918.
  • 10
    Kim, S. H., Evans, C. H., Kim, S., Oligino, T., Ghivizzani, S. C. and Robbins, P. D., Gene therapy for established murine collagen-induced arthritis by local and systemic adenovirus-mediated delivery of interleukin-4. Arthritis Res. 2000. 2: 293302.
  • 11
    Willems, F., Marchant, A., Delville, J. P., Gerard, C., Delvaux, A., Velu, T., de Boer, M. et al., Interleukin-10 inhibits B7 and intercellular adhesion molecule-1 expression on human monocytes. Eur. J. Immunol. 1994. 24: 10071009.
  • 12
    Whalen, J. D., Lechman, E. L., Carlos, C. A., Weiss, K., Kovesdi, I., Glorioso, J. C., Robbins, P. D. et al., Adenoviral transfer of the viral IL-10 gene periarticularly to mouse paws suppresses development of collagen-induced arthritis in both injected and uninjected paws. J. Immunol. 1999. 162: 36253632.
  • 13
    Quattrocchi, E., Dallman, M. J., Dhillon, A. P., Quaglia, A., Bagnato, G. and Feldmann, M., Murine IL-10 gene transfer inhibits established collagen-induced arthritis and reduces adenovirus-mediated inflammatory responses in mouse liver. J. Immunol. 2001. 166: 59705978.
  • 14
    Apparailly, F., Verwaerde, C., Jacquet, C., Auriault, C., Sany, J. and Jorgensen, C., Adenovirus mediated transfer of viral IL-10 gene inhibits collagen-induced arthritis. J. Immunol. 1998. 160: 52135220.
  • 15
    Bessis, N., Chiocchia, G., Kollias, G., Minty, A., Fournier, C., Fradelizi, D. and Boissier, M. C., Modulation of proinflammatory cytokine production in tumour necrosis factor-alpha (TNF-alpha)-transgenic mice by treatment with cells engineered to secrete IL-4, IL-10 or IL-13. Clin. Exp. Immunol. 1998. 111: 391396.
  • 16
    Kim, K. N., Watanabe, S., Ma, Y., Thornton, S., Giannini, E. H. and Hirsch, R., Viral IL-10 and soluble TNF receptor act synergistically to inhibit collagen-induced arthritis following adenovirus-mediated gene transfer. J. Immunol. 2000. 164: 15761581.
  • 17
    Johansson, A. C., Hansson, A. S., Nandakumar, K. S., Backlund, J., Holmdahl, R., IL-10-deficient B10.Q mice develop more severe collagen-induced arthritis, but are protected from arthritis induced with anti-type II collagen antibodies. J. Immunol. 2001. 167: 35053512.
  • 18
    Svensson, L., Nandakumar, K. S., Johansson, A., Jansson, L. and Holmdahl, R., IL-4-deficient mice develop less acute but more chronic relapsing collagen-induced arthritis. Eur. J. Immunol. 2002. 32: 29442953.
  • 19
    Singh, A. K., Wilson, M. T., Hong, S., Olivares-Villagomez, D., Du, C., Stanic, A. K., Joyce, S. et al., Natural killer T cell activation protects mice against experimental autoimmune encephalomyelitis. J. Exp. Med. 2001. 194: 18011811.
  • 20
    Shao, H., Van Kaer, L., Sun, S. L., Kaplan, H. J. and Sun, D., Infiltration of the inflamed eye by NKT cells in a rat model of experimental autoimmune uveitis. J. Autoimmun. 2003. 21: 3745.
  • 21
    Shibolet, O., Kalish, Y., Klein, A., Alper, R., Zolotarov, L., Thalenfeld, B., Engelhardt, D. et al., Adoptive transfer of ex vivo immune-programmed NKT lymphocytes alleviates immune-mediated colitis. J. Leukoc. Biol. 2004. 75: 7686.
  • 22
    Sharif, S., Arreaza, G. A., Zucker, P., Mi, Q. S., Sondhi, J., Naidenko, O. V., Kronenberg, M. et al., Activation of natural killer T cells by alpha-galactosylceramide treatment prevents the onset and recurrence of autoimmune Type 1 diabetes. Nat. Med. 2001. 7: 10571062.
  • 23
    Singh, A. K., Yang, J. Q., Parekh, V. V., Wei, J., Wang, C. R., Joyce, S., Singh, R. R. et al., The natural killer T cell ligand alpha-galactosylceramide prevents or promotes pristane-induced lupus in mice. Eur. J. Immunol. 2005. 35: 11431154.
  • 24
    Hammond, K. J. and Kronenberg, M., Natural killer T cells: natural or unnatural regulators of autoimmunity? Curr. Opin. Immunol. 2003. 15: 683689.
  • 25
    Bendelac, A., Rivera, M. N., Park, S. H. and Roark, J. H., Mouse CD1-specific NK1 T cells: development, specificity, and function. Annu. Rev. Immunol. 1997. 15: 535562.
  • 26
    Brigl, M. and Brenner, M. B., CD1: antigen presentation and T cell function. Annu. Rev. Immunol. 2004. 22: 817890.
  • 27
    Zhou, D., Mattner, J., Cantu, C., 3rd, Schrantz, N., Yin, N., Gao, Y., Sagiv, Y. et al., Lysosomal glycosphingolipid recognition by NKT cells. Science 2004. 306: 17861789.
  • 28
    Taniguchi, M., Harada, M., Kojo, S., Nakayama, T. and Wakao, H., The regulatory role of Valpha14 NKT cells in innate and acquired immune response. Annu. Rev. Immunol. 2003. 21: 483513.
  • 29
    Falcone, M., Facciotti, F., Ghidoli, N., Monti, P., Olivieri, S., Zaccagnino, L., Bonifacio, E. et al., Up-regulation of CD1d expression restores the immunoregulatory function of NKT cells and prevents autoimmune diabetes in nonobese diabetic mice. J. Immunol. 2004. 172: 59085916.
  • 30
    Furlan, R., Bergami, A., Cantarella, D., Brambilla, E., Taniguchi, M., Dellabona, P., Casorati, G. et al., Activation of invariant NKT cells by alphaGalCer administration protects mice from MOG35–55-induced EAE: critical roles for administration route and IFN-gamma. Eur. J. Immunol. 2003. 33: 18301838.
  • 31
    Chiba, A., Oki, S., Miyamoto, K., Hashimoto, H., Yamamura, T. and Miyake, S., Suppression of collagen-induced arthritis by natural killer T cell activation with OCH, a sphingosine-truncated analog of alpha-galactosylceramide. Arthritis Rheum. 2004. 50: 305313.
  • 32
    Courtenay, J. S., Dallman, M. J., Dayan, A. D., Martin, A. and Mosedale, B., Immunisation against heterologous type II collagen induces arthrtis in mice. Nature 1980. 283: 666668.
  • 33
    Boissier, M.-C., Feng, X. Z., Carlioz, A., Roudier, R. and Fournier, C., Experimental autoimmune arthritis in mice. I. Homologous type II collagen is responsible for self-perpetuating chronic polyarthritis. Ann. Rheum. Dis. 1987. 46: 691700.
  • 34
    Anthony, D. D. and Haqqi, T. M., Collagen-induced arthritis in mice: an animal model to study the pathogenesis of rheumatoid arthritis. Clin. Exp. Rheumatol. 1999. 17: 240244.
  • 35
    Holmdahl, R., Bockermann, R., Backlund, J. and Yamada, H., The molecular pathogenesis of collagen-induced arthritis in mice–a model for rheumatoid arthritis. Ageing Res. Rev. 2002. 1: 135147.
  • 36
    Jahng, A. W., Maricic, I., Pedersen, B., Burdin, N., Naidenko, O., Kronenberg, M., Koezuka, Y. et al., Activation of natural killer T cells potentiates or prevents experimental autoimmune encephalomyelitis. J. Exp. Med. 2001. 194: 17891799.
  • 37
    Hong, S., Wilson, M. T., Serizawa, I., Wu, L., Singh, N., Naidenko, O. V., Miura, T. et al., The natural killer T-cell ligand alpha-galactosylceramide prevents autoimmune diabetes in non-obese diabetic mice. Nat. Med. 2001. 7: 10521056.
  • 38
    Myers, L. K., Rosloniec, E. F., Cremer, M. A. and Kang, A. H., Collagen-induced arthritis, an animal model of autoimmunity. Life Sci. 1997. 61: 18611878.
  • 39
    Durie, F. H., Fava, R. A. and Noelle, R. J., Collagen-induced arthritis as a model of rheumatoid arthritis. Clin. Immunol. Immunopathol 1994. 73: 1118.
  • 40
    Campbell, I. K., Hamilton, J. A. and Wicks, I. P., Collagen-induced arthritis in C57BL/6 (H-2b) mice: new insights into an important disease model of rheumatoid arthritis. Eur. J. Immunol. 2000. 30: 15681575.
  • 41
    Pan, M., Kang, I., Craft, J. and Yin, Z., Resistance to development of collagen-induced arthritis in C57BL/6 mice is due to a defect in secondary, but not in primary, immune response. J. Clin. Immunol. 2004. 24: 481491.
  • 42
    Corthay, A., Hansson, A. S. and Holmdahl, R., T lymphocytes are not required for the spontaneous development of entheseal ossification leading to marginal ankylosis in the DBA/1 mouse. Arthritis Rheum. 2000. 43: 844851.
  • 43
    Hammond, K. J., Poulton, L. D., Palmisano, L. J., Silveira, P. A., Godfrey, D. I. and Baxter, A. G., Alpha/beta-T cell receptor (TCR)+CD4CD8 (NKT) thymocytes prevent insulin-dependent diabetes mellitus in nonobese diabetic (NOD)/Lt mice by the influence of interleukin (IL)-4 and/or IL-10. J. Exp. Med. 1998. 187: 10471056.
  • 44
    Araki, M., Kondo, T., Gumperz, J. E., Brenner, M. B., Miyake, S. and Yamamura, T., Th2 bias of CD4+ NKT cells derived from multiple sclerosis in remission. Int. Immunol. 2003. 15: 279288.
  • 45
    Perez, N., Plence, P., Millet, V., Greuet, D., Minot, C., Noel, D., Danos, O. et al., Tetracycline transcriptional silencer tightly controls transgene expression after in vivo intramuscular electrotransfer: application to interleukin 10 therapy in experimental arthritis. Hum. Gene Ther. 2002. 13: 21612172.
  • 46
    Fellowes, R., Etheridge, C. J., Coade, S., Cooper, R. G., Stewart, L., Miller, A. D. and Woo, P., Amelioration of established collagen induced arthritis by systemic IL-10 gene delivery. Gene Ther. 2000. 7: 967977.
  • 47
    Sonoda, K. H., Faunce, D. E., Taniguchi, M., Exley, M., Balk, S. and Stein-Streilein, J., NK T cell-derived IL-10 is essential for the differentiation of antigen-specific T regulatory cells in systemic tolerance. J. Immunol. 2001. 166: 4250.
  • 48
    Galli, G., Nuti, S., Tavarini, S., Galli-Stampino, L., De Lalla, C., Casorati, G., Dellabona, P. et al., Innate immune responses support adaptive immunity: NKT cells induce B cell activation. Vaccine 2003. 21 Suppl 2: S4854.
  • 49
    Kim, H. Y., Kim, H. J., Min, H. S., Kim, S., Park, W. S., Park, S. H. and Chung, D. H., NKT cells promote antibody-induced joint inflammation by suppressing transforming growth factor beta1 production. J. Exp. Med. 2005. 201: 4147.
  • 50
    Demoulins, T., Gachelin, G., Bequet, D. and Dormont, D., A biased Valpha24+ T-cell repertoire leads to circulating NKT-cell defects in a multiple sclerosis patient at the onset of his disease. Immunol. Lett. 2003. 90: 223228.
  • 51
    Wilson, S. B., Kent, S. C., Patton, K. T., Orban, T., Jackson, R. A., Exley, M., Porcelli, S. et al., Extreme Th1 bias of invariant Valpha24JalphaQ T cells in type 1 diabetes. Nature 1998. 391: 177181.
  • 52
    Yanagihara, Y., Shiozawa, K., Takai, M., Kyogoku, M. and Shiozawa, S., Natural killer (NK) T cells are significantly decreased in the peripheral blood of patients with rheumatoid arthritis (RA). Clin. Exp. Immunol. 1999. 118: 131136.
  • 53
    Kojo, S., Adachi, Y., Keino, H., Taniguchi, M. and Sumida, T., Dysfunction of T cell receptor AV24AJ18+, BV11+ double-negative regulatory natural killer T cells in autoimmune diseases. Arthritis Rheum. 2001. 44: 11271138.
  • 54
    Linsen, L., Thewissen, M., Baeten, K., Somers, V., Geusens, P., Raus, J. and Stinissen, P., Peripheral blood but not synovial fluid natural killer T cells are biased towards a Th1-like phenotype in rheumatoid arthritis. Arthritis Res. Ther. 2005. 7: R493502.
  • 55
    Nieda, M., Okai, M., Tazbirkova, A., Lin, H., Yamaura, A., Ide, K., Abraham, R. et al., Therapeutic activation of Valpha24+Vbeta11+ NKT cells in human subjects results in highly coordinated secondary activation of acquired and innate immunity. Blood 2004. 103: 383389. Epub 2003 Sep 2025.
  • 56
    Matsuda, J. L., Naidenko, O. V., Gapin, L., Nakayama, T., Taniguchi, M., Wang, C. R., Koezuka, Y. et al., Tracking the response of natural killer T cells to a glycolipid antigen using CD1d tetramers. J. Exp. Med. 2000. 192: 741754.
  • 57
    Saidenberg-Kermanac'h, N., Bessis, N., Lemeiter, D., de Vernejoul, M. C., Boissier, M. C. and Cohen-Solal, M., Interleukin-4 cellular gene therapy and osteoprotegerin decrease inflammation-associated bone resorption in collagen-induced arthritis. J. Clin. Immunol. 2004. 24: 370378.
  • 58
    Manoury-Schwartz, B., Chiocchia, G., Bessis, N., Abehsira-Amar, O., Batteux, F., Muller, S., Huang, S. et al., High susceptibility to collagen-induced arthritis in mice lacking IFN-gamma receptors. J. Immunol. 1997. 158: 55015506.
  • 59
    Vingsbo, C., Larsson, P., Andersson, M. and Holmdahl, R., Association of pepsin with type II collagen (CII) breaks control of CII autoimmunity and triggers development of arthritis in rats. Scand. J. Immunol. 1993. 37: 337342.